(GSIE) Goldman Sachs ActiveBeta - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US3814301079 • Foreign Large Blend

GSIE: ETF, International, Stocks, Depositary Receipts

The Goldman Sachs ActiveBeta® International Equity ETF (NYSE ARCA: GSIE) is designed to provide exposure to equity securities of developed market issuers outside the United States, leveraging Goldman Sachs ActiveBeta® methodology. The fund invests at least 80% of its assets in securities included in its underlying index, depositary receipts, or underlying stocks tied to depositary receipts in the index. This approach ensures targeted exposure to international developed markets while maintaining diversification.

The ETF is classified under the Foreign Large Blend category, focusing on large-cap companies across developed markets outside the U.S. Its average volume over the past 20 days is approximately 483,000 shares, with a last price of $36.88. The funds moving averages indicate a recent upward trend, with the SMA 20 at $35.10, SMA 50 at $35.70, and SMA 200 at $34.62. The Average True Range (ATR) of 0.74 reflects moderate price volatility.

As of the latest data, the funds assets under management (AUM) total $3.525 billion, underscoring its popularity as a vehicle for international equity exposure. The ETF is listed on the NYSE ARCA under the ticker symbol GSIE, offering investors a liquid and diversified way to access developed markets outside the U.S.

Over the next three months, GSIEs price action is expected to remain above its SMA 200 of $34.62, supported by its current upward momentum. The narrowing gap between the SMA 20 and SMA 50 suggests potential consolidation, while the ATR of 0.74 indicates manageable volatility. Expect price fluctuations within a range of $35.50 to $38.50, driven by broader market conditions and geopolitical factors.

From a fundamental perspective, GSIE is well-positioned to benefit from the continued economic recovery in developed international markets. With an AUM of $3.525 billion, the fund offers liquidity and scale, making it a stable choice for investors seeking exposure to non-U.S. equities. The funds focus on large-cap issuers provides a foundation for stability amid potential market uncertainties.

Additional Sources for GSIE ETF

GSIE ETF Overview

Market Cap in USD 3,855m
Category Foreign Large Blend
TER 0.25%
IPO / Inception 2015-11-06

GSIE ETF Ratings

Growth Rating 62.5
Fundamental -
Dividend Rating 59.4
Rel. Strength 0.99
Analysts -
Fair Price Momentum 37.15 USD
Fair Price DCF -

GSIE Dividends

Dividend Yield 12m 2.85%
Yield on Cost 5y 4.90%
Annual Growth 5y 21.15%
Payout Consistency 85.2%

GSIE Growth Ratios

Growth Correlation 3m 42.5%
Growth Correlation 12m 58%
Growth Correlation 5y 65.9%
CAGR 5y 12.58%
CAGR/Max DD 5y 0.42
Sharpe Ratio 12m 1.21
Alpha 2.49
Beta 0.732
Volatility 18.40%
Current Volume 268.4k
Average Volume 20d 337.2k
What is the price of GSIE stocks?
As of May 14, 2025, the stock is trading at USD 38.10 with a total of 268,439 shares traded.
Over the past week, the price has changed by +0.58%, over one month by +8.61%, over three months by +6.75% and over the past year by +13.93%.
Is Goldman Sachs ActiveBeta a good stock to buy?
Yes. Based on ValueRay Analyses, Goldman Sachs ActiveBeta (NYSE ARCA:GSIE) is currently (May 2025) a good stock to buy. It has a ValueRay Growth Rating of 62.45 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of GSIE as of May 2025 is 37.15. This means that GSIE is currently overvalued and has a potential downside of -2.49%.
Is GSIE a buy, sell or hold?
Goldman Sachs ActiveBeta has no consensus analysts rating.
What are the forecast for GSIE stock price target?
According to ValueRays Forecast Model, GSIE Goldman Sachs ActiveBeta will be worth about 42.5 in May 2026. The stock is currently trading at 38.10. This means that the stock has a potential upside of +11.5%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 42.5 11.5%